These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 4122738)

  • 1. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report.
    Lancet; 1973 Jun; 1(7816):1331-8. PubMed ID: 4122738
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1972 May; 1(7760):1079-85. PubMed ID: 4112569
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1974 Nov; 2(7889):1100-6. PubMed ID: 4139405
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. East African-British Medical Research Councils.
    Lancet; 1974 Aug; 2(7875):237-40. PubMed ID: 4135686
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of various drug regimens in domiciliary chemotherapy.
    Mehrotra ML; Pande DC; Grover KL; Gautam KD
    Am Rev Respir Dis; 1970 Oct; 102(4):607-13. PubMed ID: 4195520
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-course treatment in pulmonary tuberculosis.
    East Afr Med J; 1973 Dec; 50(12):672-80. PubMed ID: 4132127
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-course chemotherapy for pulmonary tuberculosis.
    Fox W; Mitchison DA
    Am Rev Respir Dis; 1975 Mar; 111(3):325-53. PubMed ID: 47233
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.
    S Afr Med J; 1996 Aug; 86(8):960-5. PubMed ID: 8823423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled clinical trial of the role of thiacetazone-containing regimens in the treatment of pulmonary tuberculosis in Singapore: second report.
    Tubercle; 1974 Dec; 55(4):251-60. PubMed ID: 4143454
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-course chemotherapy for pulmonary tuberculosis.
    Fox W; Mitchison DA
    Am Rev Respir Dis; 1975 Jun; 111(6):845-8 CONTD. PubMed ID: 49163
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
    Am Rev Respir Dis; 1981 Feb; 123(2):165-70. PubMed ID: 7015933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM; Bakare NA; Onadeko BO
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience with intensive short-term chemotherapy of patients with recently diagnosed destructive pulmonary tuberculosis].
    Porokhnia VV; Khomenko VV; Petrovich DI; Iusukhno EE; Skvira VP
    Probl Tuberk; 1989; (3):64-7. PubMed ID: 2726715
    [No Abstract]   [Full Text] [Related]  

  • 16. Streptomycin plus thiacetazone (thioacetazone) compared with streptomycin plus PAS and with isoniazid plus thiacetazone in the treatment of pulmonary tuberculosis in Rhodesia.
    Briggs IL; Rochester WR; Shennan DH; Riddell RW; Fox W; Heffernan JF; Miller AB; Nunn AJ; Stott H; Tall R
    Tubercle; 1968 Mar; 49(1):48-69. PubMed ID: 4173466
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
    Mitchison DA; Nunn AJ
    Am Rev Respir Dis; 1986 Mar; 133(3):423-30. PubMed ID: 2420242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled study of the combination isoniazid-thioacetazone in the treatment of lung tuberculosis].
    do Prado WT; Gomes Sde C
    AMB Rev Assoc Med Bras; 1974 Nov; 20(11):399-402. PubMed ID: 4141511
    [No Abstract]   [Full Text] [Related]  

  • 19. [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako].
    Kayantao D; Keïta B; Sangaré S
    Bull Soc Pathol Exot; 1997; 90(2):124-7. PubMed ID: 9289251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1988 May; 137(5):1147-50. PubMed ID: 2904237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.